Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-α

References

• Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1997; 29: 541–8
   PubMed Web of Science ®Google Scholar
• Lowe GD. Blood rheology in vitro and in vivo. Baillieres Clin Haematol 1987; 1: 597–636
   PubMedGoogle Scholar
• Schmidt R, Lerche D, Dorp E, Winkler R, Klinkmann H. Changes in rheology and red blood cell function under recombinant human erythropoietin therapy. Pol Arch Med Wewn 1991; 85: 384–90
   PubMedGoogle Scholar
• Linde T, Sandhagen B, Danielson BG, Wikstrom B. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin. J Intern Med 1992; 231: 601–6
   PubMed Web of Science ®Google Scholar
• Meier W, Paulitschke M, Lerche D, Schmidt G, Zoellner K. Action of rHuEpo on mechanical membrane properties of red blood cells in children with end-stage renal disease. Nephrol Dial Transplant 1991; 6: 110–6
   PubMed Web of Science ®Google Scholar
• Bohler T, Leo A, Linderkamp O, Braun A, Scharer K. Haemorheological changes in uraemic children in response to erythropoietin treatment. Nephrol Dial Transplant 1993; 8: 140–5
   PubMed Web of Science ®Google Scholar
• Biesma DH, Bronkhorst PJ, de Groot PG, van de Wiel A, Kraaijenhagen RJ, Marx JJ. The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors. J Lab Clin Med 1994; 124: 42–7
   PubMed Web of Science ®Google Scholar
• Metry G, Wikstrom B, Valind S, Sandhagen B, Linde T, Beshara S, et al. Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol 1999; 10: 854–63
   PubMed Web of Science ®Google Scholar
• Macdougall IC, Davies ME, Hutton RD, Coles GA, Williams JD. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin. Br J Haematol 1991; 77: 550–8
   PubMed Web of Science ®Google Scholar
• Bor-Kucukatay M, Yalcin O, Meiselman HJ, Baskurt OK. Erythropoietin-induced rheological changes of rat erythrocytes. Br J Haematol 2000; 110: 82–8
   PubMed Web of Science ®Google Scholar
• Linde T, Sandhagen B, Hagg A, Morlin C, Danielson BG. Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study. J Hum Hypertens 1996; 10: 199–205
   PubMed Web of Science ®Google Scholar
• Murphy ST, Parfrey PS. The impact of anemia correction on cardiovascular disease in end-stage renal disease. Semin Nephrol 2000; 20: 350–5
   PubMed Web of Science ®Google Scholar
• Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 1991; 35: 280–7
   PubMed Web of Science ®Google Scholar
• Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 2000; 35: 250–6
   PubMed Web of Science ®Google Scholar
• Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003; 18: 353–61
   PubMed Web of Science ®Google Scholar
• Sandhagen B. Analysis of haemorheological variables—methodology and reference values. Uppsala J Med Sci 1989; 94: 81–7
   PubMed Web of Science ®Google Scholar
• International Committee for Standardization in Haematology (ICSH). Guidelines for measurement of blood viscosity and deformability. Clin Hemorheol 1986; 6: 439–53
   Google Scholar
• Rampling M, Whittingstall P. A comparison of five methods for estimating red cell aggregation. Klin Wochenschr 1986; 64: 1084–8
   PubMedGoogle Scholar
• Stäubli M, Stone P, Straub P, Stuart J. Evaluation of methods for measuring erythrocyte deformability. Clin Hemorheol 1986; 6: 589–602
   Google Scholar
• Sahn D, De Maria A, Kisso J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
   PubMed Web of Science ®Google Scholar
• Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987; 9: II9–26
   Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
   PubMed Web of Science ®Google Scholar
• Linde T, Sandhagen B, Hagg A, Morlin C, Wikstrom B, Danielson BG. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens 1993; 11: 731–6
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325–35
   PubMed Web of Science ®Google Scholar
• Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999; 33: 821–8
   PubMed Web of Science ®Google Scholar
• Levin A, Thompson C, Ethier J, Carlisle EJF, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125–34
   PubMed Web of Science ®Google Scholar
• Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147–52
   PubMed Web of Science ®Google Scholar